Three cases of manifesting female carriers in patients with duchenne muscular dystrophy

Yonsei Medical Journal

Volumn 52, Issue 1, 2011, Pages 192-195

  Song, Tae Jin ^a   Lee, Kyung A ^a   Kang, Seong Woong ^a   Cho, Hanna ^a   Choi, Young Chul ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Dystrophinopathy; Female carrier; Multiplex ligation dependent probe amplification

Indexed keywords

CREATINE KINASE; DYSTROPHIN;

ADULT; ARM; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CARRIER; DUCHENNE MUSCULAR DYSTROPHY; DYSTROPHINOPATHY; ELECTROMYOGRAPHY; FAMILY HISTORY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LEG; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOPATHY; ONSET AGE; SCHOOL CHILD;

ADULT; CHILD; FEMALE; HUMANS; MUSCULAR DYSTROPHY, DUCHENNE;

EID: 78650618417     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2011.52.1.192     Document Type: Article

References (14)

1. Walcher T, Kunze M, Steinbach P, Sperfeld AD, Burgstahler C, Hombach V, et al. Cardiac involvement in a female carrier of Duchenne muscular dystrophy. Int J Cardiol 2010; 138: 302-5.
2. Ceulemans BP, Storm K, Reyniers E Jr, Callewaert L, Martin JJ. Muscle pain as the only presenting symptom in a girl with dystrophinopathy. Pediatr Neurol 2008; 38: 64-6.
3. Hoffman EP, Arahata K, Minetti C, Bonilla E, Rowland LP. Dystrophinopathy in isolated cases of myopathy in females. Neurology 1992; 42: 967-75.
4. Hoogerwaard EM, Bakker E, Ippel PF, Oosterwijk JC, Majoor-Krakauer DF, Leschot NJ, et al. Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study. Lancet 1999; 353: 2116-9.
5. Griggs RC, Mendell JR, Brooke MH, Fenichel GM, Miller JP, Province M, et al. Clinical investigation in Duchenne dystrophy: V. Use of creatine kinase and pyruvate kinase in carrier detection. Muscle Nerve 1985; 8: 60-7.
6. Politano L, Nigro V, Nigro G, Petretta VR, Passamano L, Papparella S, et al. Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies. JAMA 1996; 275: 1335-8.
7. Lukasik E. Electrocardiographic studies in female carriers of Duchenne muscular dystrophy. J Neurol 1975; 209: 279-85.
8. Hoffman EP, Brown RH Jr, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987; 51: 919-28.
9. Arahata K, Ishihara T, Kamakura K, Tsukahara T, Ishiura S, Baba C, et al. Mosaic expression of dystrophin in symptomatic carriers of Duchenne's muscular dystrophy. N Engl J Med 1989; 320: 138-42.
10. Chamberlain JS, Gibbs RA, Ranier JE, Nguyen PN, Caskey CT. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res 1988; 16: 11141-56.
11. Beggs AH, Koenig M, Boyce FM, Kunkel LM. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet 1990; 86: 45-8.
12. Kunkel LM, Snyder JR, Beggs AH, Boyce FM, Feener CA. Searching for dystrophin gene deletions in patients with atypical presentations. In: Lindsten J, Petterson U, editors. Etiology of Human Diseases at the DNA Level. New York: Raven Press; 1991.p. 51-60.
13. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic AcidsYonsei Med J http://www.eymj.org Volume 52 Number 1 January 2011 195 Res 2002; 30: e57.
14. Schwartz M, Dunø M. Multiplex ligation-dependent probe amplification is superior for detecting deletions/duplications in Duchenne muscular dystrophy. Clin Genet 2005; 67: 189-91.